Global Prostaglandins and Related Drugs Supply, Demand and Key Producers, 2023-2029

May 2023 | 102 pages | ID: G71C91D1AADFEN
GlobalInfoResearch

Abstracts

The global Prostaglandins and Related Drugs market size is expected to reach $ 317.9 million by 2029, rising at a market growth of 5.5% CAGR during the forecast period (2023-2029).

Prostaglandins are a group of hormone-like substances that are produced by the body and have a wide range of physiological effects. They are derived from arachidonic acid, which is an essential fatty acid found in cell membranes. Prostaglandins are involved in a variety of processes, including inflammation, blood clotting, regulation of blood pressure, and the contraction and relaxation of smooth muscle tissue.

This report studies the global Prostaglandins and Related Drugs demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Prostaglandins and Related Drugs, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Prostaglandins and Related Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Prostaglandins and Related Drugs total market, 2018-2029, (USD Million)

Global Prostaglandins and Related Drugs total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Prostaglandins and Related Drugs total market, key domestic companies and share, (USD Million)

Global Prostaglandins and Related Drugs revenue by player and market share 2018-2023, (USD Million)

Global Prostaglandins and Related Drugs total market by Type, CAGR, 2018-2029, (USD Million)

Global Prostaglandins and Related Drugs total market by Application, CAGR, 2018-2029, (USD Million)

This reports profiles major players in the global Prostaglandins and Related Drugs market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Toray Industries, Kaken Pharmaceutical, United Therapeutics, Jeil Pharmaceutical, Beijing Tide Pharmaceutical and Lee's Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Prostaglandins and Related Drugs market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Prostaglandins and Related Drugs Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Prostaglandins and Related Drugs Market, Segmentation by Type

• Beraprost
• Treprostinil

Global Prostaglandins and Related Drugs Market, Segmentation by Application

• Hospital
• Clinic
• Other

Companies Profiled:

• Toray Industries
• Kaken Pharmaceutical
• United Therapeutics
• Jeil Pharmaceutical
• Beijing Tide Pharmaceutical
• Lee's Pharmaceutical

Key Questions Answered

1. How big is the global Prostaglandins and Related Drugs market?

2. What is the demand of the global Prostaglandins and Related Drugs market?

3. What is the year over year growth of the global Prostaglandins and Related Drugs market?

4. What is the total value of the global Prostaglandins and Related Drugs market?

5. Who are the major players in the global Prostaglandins and Related Drugs market?

6. What are the growth factors driving the market demand?

Contents

1 SUPPLY SUMMARY

1.1 Prostaglandins and Related Drugs Introduction
1.2 World Prostaglandins and Related Drugs Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Prostaglandins and Related Drugs Total Market by Region (by Headquarter Location)
  1.3.1 World Prostaglandins and Related Drugs Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Prostaglandins and Related Drugs Market Size (2018-2029)
  1.3.3 China Prostaglandins and Related Drugs Market Size (2018-2029)
  1.3.4 Europe Prostaglandins and Related Drugs Market Size (2018-2029)
  1.3.5 Japan Prostaglandins and Related Drugs Market Size (2018-2029)
  1.3.6 South Korea Prostaglandins and Related Drugs Market Size (2018-2029)
  1.3.7 ASEAN Prostaglandins and Related Drugs Market Size (2018-2029)
  1.3.8 India Prostaglandins and Related Drugs Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Prostaglandins and Related Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Prostaglandins and Related Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Prostaglandins and Related Drugs Consumption Value (2018-2029)
2.2 World Prostaglandins and Related Drugs Consumption Value by Region
  2.2.1 World Prostaglandins and Related Drugs Consumption Value by Region (2018-2023)
  2.2.2 World Prostaglandins and Related Drugs Consumption Value Forecast by Region (2024-2029)
2.3 United States Prostaglandins and Related Drugs Consumption Value (2018-2029)
2.4 China Prostaglandins and Related Drugs Consumption Value (2018-2029)
2.5 Europe Prostaglandins and Related Drugs Consumption Value (2018-2029)
2.6 Japan Prostaglandins and Related Drugs Consumption Value (2018-2029)
2.7 South Korea Prostaglandins and Related Drugs Consumption Value (2018-2029)
2.8 ASEAN Prostaglandins and Related Drugs Consumption Value (2018-2029)
2.9 India Prostaglandins and Related Drugs Consumption Value (2018-2029)

3 WORLD PROSTAGLANDINS AND RELATED DRUGS COMPANIES COMPETITIVE ANALYSIS

3.1 World Prostaglandins and Related Drugs Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Prostaglandins and Related Drugs Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Prostaglandins and Related Drugs in 2022
  3.2.3 Global Concentration Ratios (CR8) for Prostaglandins and Related Drugs in 2022
3.3 Prostaglandins and Related Drugs Company Evaluation Quadrant
3.4 Prostaglandins and Related Drugs Market: Overall Company Footprint Analysis
  3.4.1 Prostaglandins and Related Drugs Market: Region Footprint
  3.4.2 Prostaglandins and Related Drugs Market: Company Product Type Footprint
  3.4.3 Prostaglandins and Related Drugs Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Prostaglandins and Related Drugs Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Prostaglandins and Related Drugs Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Prostaglandins and Related Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Prostaglandins and Related Drugs Consumption Value Comparison
  4.2.1 United States VS China: Prostaglandins and Related Drugs Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Prostaglandins and Related Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Prostaglandins and Related Drugs Companies and Market Share, 2018-2023
  4.3.1 United States Based Prostaglandins and Related Drugs Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Prostaglandins and Related Drugs Revenue, (2018-2023)
4.4 China Based Companies Prostaglandins and Related Drugs Revenue and Market Share, 2018-2023
  4.4.1 China Based Prostaglandins and Related Drugs Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Prostaglandins and Related Drugs Revenue, (2018-2023)
4.5 Rest of World Based Prostaglandins and Related Drugs Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Prostaglandins and Related Drugs Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Prostaglandins and Related Drugs Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Prostaglandins and Related Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Beraprost
  5.2.2 Treprostinil
5.3 Market Segment by Type
  5.3.1 World Prostaglandins and Related Drugs Market Size by Type (2018-2023)
  5.3.2 World Prostaglandins and Related Drugs Market Size by Type (2024-2029)
  5.3.3 World Prostaglandins and Related Drugs Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Prostaglandins and Related Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Clinic
  6.2.3 Other
6.3 Market Segment by Application
  6.3.1 World Prostaglandins and Related Drugs Market Size by Application (2018-2023)
  6.3.2 World Prostaglandins and Related Drugs Market Size by Application (2024-2029)
  6.3.3 World Prostaglandins and Related Drugs Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Toray Industries
  7.1.1 Toray Industries Details
  7.1.2 Toray Industries Major Business
  7.1.3 Toray Industries Prostaglandins and Related Drugs Product and Services
  7.1.4 Toray Industries Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Toray Industries Recent Developments/Updates
  7.1.6 Toray Industries Competitive Strengths & Weaknesses
7.2 Kaken Pharmaceutical
  7.2.1 Kaken Pharmaceutical Details
  7.2.2 Kaken Pharmaceutical Major Business
  7.2.3 Kaken Pharmaceutical Prostaglandins and Related Drugs Product and Services
  7.2.4 Kaken Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Kaken Pharmaceutical Recent Developments/Updates
  7.2.6 Kaken Pharmaceutical Competitive Strengths & Weaknesses
7.3 United Therapeutics
  7.3.1 United Therapeutics Details
  7.3.2 United Therapeutics Major Business
  7.3.3 United Therapeutics Prostaglandins and Related Drugs Product and Services
  7.3.4 United Therapeutics Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 United Therapeutics Recent Developments/Updates
  7.3.6 United Therapeutics Competitive Strengths & Weaknesses
7.4 Jeil Pharmaceutical
  7.4.1 Jeil Pharmaceutical Details
  7.4.2 Jeil Pharmaceutical Major Business
  7.4.3 Jeil Pharmaceutical Prostaglandins and Related Drugs Product and Services
  7.4.4 Jeil Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Jeil Pharmaceutical Recent Developments/Updates
  7.4.6 Jeil Pharmaceutical Competitive Strengths & Weaknesses
7.5 Beijing Tide Pharmaceutical
  7.5.1 Beijing Tide Pharmaceutical Details
  7.5.2 Beijing Tide Pharmaceutical Major Business
  7.5.3 Beijing Tide Pharmaceutical Prostaglandins and Related Drugs Product and Services
  7.5.4 Beijing Tide Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Beijing Tide Pharmaceutical Recent Developments/Updates
  7.5.6 Beijing Tide Pharmaceutical Competitive Strengths & Weaknesses
7.6 Lee's Pharmaceutical
  7.6.1 Lee's Pharmaceutical Details
  7.6.2 Lee's Pharmaceutical Major Business
  7.6.3 Lee's Pharmaceutical Prostaglandins and Related Drugs Product and Services
  7.6.4 Lee's Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Lee's Pharmaceutical Recent Developments/Updates
  7.6.6 Lee's Pharmaceutical Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Prostaglandins and Related Drugs Industry Chain
8.2 Prostaglandins and Related Drugs Upstream Analysis
8.3 Prostaglandins and Related Drugs Midstream Analysis
8.4 Prostaglandins and Related Drugs Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Prostaglandins and Related Drugs Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Prostaglandins and Related Drugs Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Prostaglandins and Related Drugs Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Prostaglandins and Related Drugs Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Prostaglandins and Related Drugs Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Prostaglandins and Related Drugs Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Prostaglandins and Related Drugs Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Prostaglandins and Related Drugs Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Prostaglandins and Related Drugs Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Prostaglandins and Related Drugs Players in 2022
Table 12. World Prostaglandins and Related Drugs Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Prostaglandins and Related Drugs Company Evaluation Quadrant
Table 14. Head Office of Key Prostaglandins and Related Drugs Player
Table 15. Prostaglandins and Related Drugs Market: Company Product Type Footprint
Table 16. Prostaglandins and Related Drugs Market: Company Product Application Footprint
Table 17. Prostaglandins and Related Drugs Mergers & Acquisitions Activity
Table 18. United States VS China Prostaglandins and Related Drugs Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Prostaglandins and Related Drugs Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Prostaglandins and Related Drugs Companies, Headquarters (States, Country)
Table 21. United States Based Companies Prostaglandins and Related Drugs Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Prostaglandins and Related Drugs Revenue Market Share (2018-2023)
Table 23. China Based Prostaglandins and Related Drugs Companies, Headquarters (Province, Country)
Table 24. China Based Companies Prostaglandins and Related Drugs Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Prostaglandins and Related Drugs Revenue Market Share (2018-2023)
Table 26. Rest of World Based Prostaglandins and Related Drugs Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Prostaglandins and Related Drugs Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Prostaglandins and Related Drugs Revenue Market Share (2018-2023)
Table 29. World Prostaglandins and Related Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Prostaglandins and Related Drugs Market Size by Type (2018-2023) & (USD Million)
Table 31. World Prostaglandins and Related Drugs Market Size by Type (2024-2029) & (USD Million)
Table 32. World Prostaglandins and Related Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Prostaglandins and Related Drugs Market Size by Application (2018-2023) & (USD Million)
Table 34. World Prostaglandins and Related Drugs Market Size by Application (2024-2029) & (USD Million)
Table 35. Toray Industries Basic Information, Area Served and Competitors
Table 36. Toray Industries Major Business
Table 37. Toray Industries Prostaglandins and Related Drugs Product and Services
Table 38. Toray Industries Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Toray Industries Recent Developments/Updates
Table 40. Toray Industries Competitive Strengths & Weaknesses
Table 41. Kaken Pharmaceutical Basic Information, Area Served and Competitors
Table 42. Kaken Pharmaceutical Major Business
Table 43. Kaken Pharmaceutical Prostaglandins and Related Drugs Product and Services
Table 44. Kaken Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Kaken Pharmaceutical Recent Developments/Updates
Table 46. Kaken Pharmaceutical Competitive Strengths & Weaknesses
Table 47. United Therapeutics Basic Information, Area Served and Competitors
Table 48. United Therapeutics Major Business
Table 49. United Therapeutics Prostaglandins and Related Drugs Product and Services
Table 50. United Therapeutics Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. United Therapeutics Recent Developments/Updates
Table 52. United Therapeutics Competitive Strengths & Weaknesses
Table 53. Jeil Pharmaceutical Basic Information, Area Served and Competitors
Table 54. Jeil Pharmaceutical Major Business
Table 55. Jeil Pharmaceutical Prostaglandins and Related Drugs Product and Services
Table 56. Jeil Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Jeil Pharmaceutical Recent Developments/Updates
Table 58. Jeil Pharmaceutical Competitive Strengths & Weaknesses
Table 59. Beijing Tide Pharmaceutical Basic Information, Area Served and Competitors
Table 60. Beijing Tide Pharmaceutical Major Business
Table 61. Beijing Tide Pharmaceutical Prostaglandins and Related Drugs Product and Services
Table 62. Beijing Tide Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Beijing Tide Pharmaceutical Recent Developments/Updates
Table 64. Lee's Pharmaceutical Basic Information, Area Served and Competitors
Table 65. Lee's Pharmaceutical Major Business
Table 66. Lee's Pharmaceutical Prostaglandins and Related Drugs Product and Services
Table 67. Lee's Pharmaceutical Prostaglandins and Related Drugs Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 68. Global Key Players of Prostaglandins and Related Drugs Upstream (Raw Materials)
Table 69. Prostaglandins and Related Drugs Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Prostaglandins and Related Drugs Picture
Figure 2. World Prostaglandins and Related Drugs Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Prostaglandins and Related Drugs Total Market Size (2018-2029) & (USD Million)
Figure 4. World Prostaglandins and Related Drugs Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Prostaglandins and Related Drugs Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Prostaglandins and Related Drugs Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Prostaglandins and Related Drugs Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Prostaglandins and Related Drugs Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Prostaglandins and Related Drugs Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Prostaglandins and Related Drugs Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Prostaglandins and Related Drugs Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Prostaglandins and Related Drugs Revenue (2018-2029) & (USD Million)
Figure 13. Prostaglandins and Related Drugs Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 16. World Prostaglandins and Related Drugs Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 18. China Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 23. India Prostaglandins and Related Drugs Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Prostaglandins and Related Drugs by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Prostaglandins and Related Drugs Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Prostaglandins and Related Drugs Markets in 2022
Figure 27. United States VS China: Prostaglandins and Related Drugs Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Prostaglandins and Related Drugs Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Prostaglandins and Related Drugs Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Prostaglandins and Related Drugs Market Size Market Share by Type in 2022
Figure 31. Beraprost
Figure 32. Treprostinil
Figure 33. World Prostaglandins and Related Drugs Market Size Market Share by Type (2018-2029)
Figure 34. World Prostaglandins and Related Drugs Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Prostaglandins and Related Drugs Market Size Market Share by Application in 2022
Figure 36. Hospital
Figure 37. Clinic
Figure 38. Other
Figure 39. Prostaglandins and Related Drugs Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source